Exploring the future of diagnostics in the UK

By Aiden Hannah, Research Analyst, Deloitte

LSHC blog banner image 3 Dec

In November 2020 our report, ‘The future unmasked: Predicting the future of healthcare and life sciences in 2025’ included a prediction that technological breakthroughs would create new diagnostic pathways, enabling clinicians to deliver hyper-personalised evidence-based prevention and treatment interventions.1 Over the past year the pandemic has continued to have a significant impact upon the healthcare industry, in particular the diagnostics industry. This week’s blog, by our new analyst Aiden Hannah, considers the lasting impact of some of these changes and what the diagnostics landscape may look like in the future.

Continue reading

Posted on 03/12/2021 | 0 Comments

Healthcare regulation in England is changing: how should ICSs and ICBs respond?

By Matt Quinn, Manager and Dan Donaghy, Director, UK Public Sector Enterprise Operations team

LSHC blog banner image 25 Nov

The impending establishment of Integrated Care Boards (ICBs) as statutory entities from April 2022 means that regulators are adapting their regulatory models. This is to ensure a proportionate response for a ‘Systems’ based world. This also heralds a period of flux for health and social care regulation in England at a time of unprecedented demand and operational pressure precipitated by the pandemic. Health and social care organisations will need to respond to this new regulatory regime and change their operating models to ensure their leadership, financial, safety and quality performance meet regulatory expectations. In this blog, we discuss some suggested areas of change informed by our recent work in the area.

Continue reading

Posted on 25/11/2021 | 0 Comments

The Future of Public Health: Identifying the gap

By Karen Taylor and Samrina Bhatti, Deloitte Centre for Health Solutions

LSHC blog banner image 19 Nov

On 9 November, we launched the second in our future of public health report series, Identifying the gap; Understanding the drivers of inequality in public health. This report examines the who what and why of public health and the political social and economic drivers affecting public health. It also explains why learning the lessons from the past, including the lessons learned in responding to the COVID-19 pandemic, is crucial if the UK is to avoid repeating past mistakes and their reforms of the public health system are to be effective. This week’s blog explores  the historical and current challenges and approaches being taken to tackle the ‘wicked problems’ affecting public health.

Continue reading

Posted on 19/11/2021 | 0 Comments

Movember 2021: Grow a 'mo’ to save a ‘bro’ - raising awareness for men’s health

By Andy Haywood, Campaign Account Manager, Deloitte

LSHC blog banner image 12 Nov

Movember is upon us, marked by the emergence of upper-lip fuzz on men across the world. Since 2003, the Movember Foundation’s unrelenting goal has been to raise awareness of men’s health issues, with a particular focus on prostate cancer, testicular cancer and mental health and suicide prevention. Movember also seeks to challenge the status quo, shake up men’s health research and transform the way health services reach and support men. During the month formerly known as November, Mo Bros and Mo Sisters around the world rally in support of the cause to get people talking about these vital health issues. This week’s blog is my contribution to raising awareness, hoping to encourage my friends, family and colleagues to talk to the men in their lives about their health.

Continue reading

Posted on 12/11/2021 | 0 Comments

COP26 – Our hopes for a healthier, collaborative, interconnected future

By Giles Dean, Sustainability Manager, and James Gregson, Partner, UK Life Sciences and Healthcare leader


The research evidence is unequivocal, public, planetary and economic health are inextricably linked and no continent, country or community is immune from the impacts of climate change. The race to net zero is also a race to a healthier, cleaner and more resilient future. We hope that the undeniable link between improving the health outcomes of society and a successful net-zero transition will be central to COP26. This blog outlines a discussion between Giles Dean, Sustainability Manager at Deloitte UK,  and James Gregson, Partner and UK Life Sciences and Healthcare leader, on their hopes for COP26 and the implications for healthcare and, specifically the pharmaceutical (pharma) industry, across not just environmental, but also social and governance (ESG) indicators.1

Continue reading

Posted on 03/11/2021 | 0 Comments

The Future of Public Health: Narrowing the gap

By Karen Taylor and Samrina Bhatti, Deloitte Centre for Health Solutions

Future of Public Health

Over the past seven months, we have been developing a series of reports examining the current challenges and future requirements for a resilient public health system in the UK. This week we launched the first report in the series, Narrowing the gap: A fairer and sustainable future for public health.1 This report is an executive overview highlighting the key findings from a series of deep dive reports into the crucial challenges facing public health. This week’s blog provides highlights from our overview report and a taster of what to expect from our report series which we will launch over the next few weeks.

Continue reading

Posted on 29/10/2021 | 0 Comments

Baby Loss Awareness Week 2021: a personal perspective

By Elizabeth Hampson, Director, Monitor Deloitte

Baby Loss Awareness Week 2021 a personal perspective

Last week, from 9th to 15th October 2021, it was Baby Loss Awareness Week (BLAW), which is now in its 19th year.1 The objective of BLAW is to raise awareness nationally about those who have been affected by pregnancy and experienced baby loss in the UK. This year’s theme is Wellbeing and throughout the week bereaved parents and their families and friends unite with others across the world to commemorate the lives of babies lost. In this week’s blog, our colleague Liz Hampson shares her personal experience with baby loss with the aim of increasing transparency and the support provided by employers.

Continue reading

Posted on 22/10/2021 | 0 Comments

Value-based contracting is gaining traction… is medtech ready?

By Adam Lowry, Advisory Senior Manager, Deloitte and Touche LLP


In the sixth prediction of our report The Future Unmasked, we predict that long-term value-based care (VBC) arrangements for medtech companies will differentiate products that offer protection from price erosion, create long-lasting relationships with customers, and increase market share and revenue by being a preferred product in 2025.1 A major aspect in achieving this future is to promote new payment models that use innovative contracting and value-based arrangements. This week’s blog, by Adam Lowry, an advisory senior manager specialising in value based care and population health strategy for providers and health plans, appeared first as a US Center for Health Solutions, Health Forward Blog and explores how value-based contracting could benefit stakeholders across the medtech ecosystem.

Continue reading

Posted on 14/10/2021 | 0 Comments

How digital health apps are empowering patients, improving outcomes, and increasing accessibility

By Emily May, Research Analyst, Deloitte Centre for Health Solutions

Digital health

Did you know that in 2020 more than 90,000 new digital health applications (apps) were added to app stores, more than 250 new apps on average, every day?1 Neither did I until conducting some research for a conference panel a couple of weeks ago. Digital health apps range from providing a platform for services such as virtual GP appointments and chronic disease management to consumer health apps that help people manage their own health through tracking daily steps and accessing exercise and nutrition programmes. This blog explores the current use of digital health apps, how the COVID-19 pandemic has accelerated their adoption, the ethical and regulatory considerations, and the potential of these apps to drive a preventative, digital-first healthcare future.

Continue reading

Posted on 08/10/2021 | 0 Comments

These strategies could boost diversity in clinical trials

By Margaret Anderson, managing director, Deloitte Consulting LLP

Clinical trials take data from a small, but representative selection of subjects and generalise the findings to the wider population. However, as we have discussed in our previous blogs on the subject, Why improving inclusion and diversity in clinical trials should be a research priority and Diversity and inclusion in clinical trials – an imperative, especially in times of COVID-19, overcoming the lack of diversity in clinical trials is a medical and ethical imperative to achieve true representation of the patient population. This week’s blog, by Margaret Anderson, our Strategy & Analytics Diversity, Equity and Inclusion Leader in Deloitte Consulting, appeared first as a US Center for Health Solutions, Health Forward Blog and reflects on the stakeholder interviews our US colleagues conducted to understand how diversity could be improved in clinical trials.

Continue reading

Posted on 01/10/2021 | 0 Comments

How should Medtech companies respond to an increasingly consumer-centric world?

By Glenn Snyder, principal, Benjamin Ninio, managing director, and Erik Kiær, managing director, Deloitte Consulting LLP


MedTech companies have a considerable role in driving the future of health, using transformative technology to enhance products and services and enabling predictive, preventative, personalised and participatory (4P) medicine, as we highlighted in the sixth prediction of our report, ‘The future unmasked, predicting the future of healthcare and life sciences in 2025’. A major aspect of achieving this future is the move to value-based models of care and funding. This week’s blog, by Glenn Snyder, our MedTech Practice leader in Deloitte Consulting, Benjamin Ninio, managing director in Monitor Deloitte, and Erik Kiær cofounder of Deloitte Launch, appeared first as a US Center for Health Solutions, Health Forward Blog and explores how medtech companies could transform to respond to this changing health ecosystem.

Continue reading

Posted on 24/09/2021 | 0 Comments